Fabrazyme - supply shortage
Resolved
agalsidase beta
Shortage
Human
Shortage information
The shortage affecting Fabrazyme has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- Fabrazyme
- Supply shortage status
- Resolved
- International non-proprietary name (INN) or common name
- agalsidase beta
- Therapeutic area (MESH)
- Fabry Disease
- Pharmaceutical forms affected
- Powder for concentrate for solution for infusion
- Strengths affected
- 5 mg
- 35 mg
- Availability of alternatives
- No
Key dates
- First published
- Last updated